Literature DB >> 18314222

Experimental models of hepatocellular carcinoma.

Philippa Newell1, Augusto Villanueva, Scott L Friedman, Kazuhiko Koike, Josep M Llovet.   

Abstract

Hepatocellular carcinoma (HCC) is a common and deadly cancer whose pathogenesis is incompletely understood. Comparative genomic studies from human HCC samples have classified HCCs into different molecular subgroups; yet, the unifying feature of this tumor is its propensity to arise upon a background of inflammation and fibrosis. This review seeks to analyze the available experimental models in HCC research and to correlate data from human populations with them in order to consolidate our efforts to date, as it is increasingly clear that different models will be required to mimic different subclasses of the neoplasm. These models will be instrumental in the evaluation of compounds targeting specific molecular pathways in future preclinical studies.

Entities:  

Mesh:

Year:  2008        PMID: 18314222      PMCID: PMC2990959          DOI: 10.1016/j.jhep.2008.01.008

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  195 in total

Review 1.  Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection.

Authors:  Bud C Tennant; Ilia A Toshkov; Simon F Peek; James R Jacob; Stephan Menne; William E Hornbuckle; Raymond D Schinazi; Brent E Korba; Paul J Cote; John L Gerin
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

2.  Thioacetamide-induced hepatic fibrosis in transforming growth factor beta-1 transgenic mice.

Authors:  János Schnur; Julia Oláh; Agota Szepesi; Péter Nagy; Snorri S Thorgeirsson
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-02       Impact factor: 2.566

3.  'Designer' tumors in mice.

Authors:  Katerina Politi; Ana Kljuic; Matthias Szabolcs; Peter Fisher; Thomas Ludwig; Argiris Efstratiadis
Journal:  Oncogene       Date:  2004-02-26       Impact factor: 9.867

4.  Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.

Authors:  Yasuo Horie; Akira Suzuki; Ei Kataoka; Takehiko Sasaki; Koichi Hamada; Junko Sasaki; Katsunori Mizuno; Go Hasegawa; Hiroyuki Kishimoto; Masahiro Iizuka; Makoto Naito; Katsuhiko Enomoto; Sumio Watanabe; Tak Wah Mak; Toru Nakano
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

Review 5.  Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice.

Authors:  Annapoorni Rangarajan; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2003-12       Impact factor: 60.716

6.  Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations.

Authors:  Naomoto Harada; Hiroko Oshima; Masahiro Katoh; Yositaka Tamai; Masanobu Oshima; Makoto M Taketo
Journal:  Cancer Res       Date:  2004-01-01       Impact factor: 12.701

7.  Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma.

Authors:  Ruben R Plentz; Martin Caselitz; Joerg S Bleck; Michael Gebel; Peer Flemming; Stefan Kubicka; Michael P Manns; K Lenhard Rudolph
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

Review 8.  Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.

Authors:  L R Kelland
Journal:  Eur J Cancer       Date:  2004-04       Impact factor: 9.162

9.  Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.

Authors:  Diego F Calvisi; Sara Ladu; Valentina M Factor; Snorri S Thorgeirsson
Journal:  Carcinogenesis       Date:  2004-01-23       Impact factor: 4.944

10.  mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.

Authors:  Pradip K Majumder; Phillip G Febbo; Rachel Bikoff; Raanan Berger; Qi Xue; Louis M McMahon; Judith Manola; James Brugarolas; Timothy J McDonnell; Todd R Golub; Massimo Loda; Heidi A Lane; William R Sellers
Journal:  Nat Med       Date:  2004-05-23       Impact factor: 53.440

View more
  74 in total

1.  Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies.

Authors:  Allyson K Martínez; Luca Maroni; Marco Marzioni; Syed T Ahmed; Mena Milad; Debolina Ray; Gianfranco Alpini; Shannon S Glaser
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

Review 2.  Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma.

Authors:  Igor P Pogribny; Ivan Rusyn
Journal:  Cancer Lett       Date:  2012-02-02       Impact factor: 8.679

3.  Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma.

Authors:  Zhenyu Xiao; Haniee Chung; Babak Banan; Pamela T Manning; Katherine C Ott; Shin Lin; Benjamin J Capoccia; Vijay Subramanian; Ronald R Hiebsch; Gundumi A Upadhya; Thalachallour Mohanakumar; William A Frazier; Yiing Lin; William C Chapman
Journal:  Cancer Lett       Date:  2015-02-23       Impact factor: 8.679

4.  Telomere Dysfunction Induces Sirtuin Repression that Drives Telomere-Dependent Disease.

Authors:  Hisayuki Amano; Arindam Chaudhury; Cristian Rodriguez-Aguayo; Lan Lu; Viktor Akhanov; Andre Catic; Yury V Popov; Eric Verdin; Hannah Johnson; Fabio Stossi; David A Sinclair; Eiko Nakamaru-Ogiso; Gabriel Lopez-Berestein; Jeffrey T Chang; Joel R Neilson; Alan Meeker; Milton Finegold; Joseph A Baur; Ergun Sahin
Journal:  Cell Metab       Date:  2019-03-28       Impact factor: 27.287

Review 5.  Characterization of animal models for primary sclerosing cholangitis (PSC).

Authors:  Peter Fickert; Marion J Pollheimer; Ulrich Beuers; Carolin Lackner; Gideon Hirschfield; Chantal Housset; Verena Keitel; Christoph Schramm; Hanns-Ulrich Marschall; Tom H Karlsen; Espen Melum; Arthur Kaser; Bertus Eksteen; Mario Strazzabosco; Michael Manns; Michael Trauner
Journal:  J Hepatol       Date:  2014-02-19       Impact factor: 25.083

6.  The search for precision models clinically relevant to human liver cancer.

Authors:  Wen Xue; Xin W Wang
Journal:  Hepat Oncol       Date:  2015-11-06

Review 7.  Mouse models for liver cancer.

Authors:  Latifa Bakiri; Erwin F Wagner
Journal:  Mol Oncol       Date:  2013-02-05       Impact factor: 6.603

8.  DNA damage-induced sustained p53 activation contributes to inflammation-associated hepatocarcinogenesis in rats.

Authors:  H-X Yan; H-P Wu; H-L Zhang; C Ashton; C Tong; J Wu; Q-J Qian; H-Y Wang; Q-L Ying
Journal:  Oncogene       Date:  2012-10-15       Impact factor: 9.867

Review 9.  Molecular targeted therapies in hepatocellular carcinoma.

Authors:  Josep M Llovet; Jordi Bruix
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

10.  Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat.

Authors:  Meng Fang; Sylviane Dewaele; Yun-Peng Zhao; Peter Stärkel; Valerie Vanhooren; Yue-Ming Chen; Xin Ji; Ming Luo; Bao-Mu Sun; Yves Horsmans; Anne Dell; Stuart M Haslam; Paola Grassi; Claude Libert; Chun-Fang Gao; Cuiying Chitty Chen
Journal:  Mol Cancer       Date:  2010-08-12       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.